Please Wait...

Bioclinica Appoints David Herron as Chief Executive Officer

Dr. John Hubbard, current CEO, assumes non-Executive Board of Directors role

November 29, 2017

DOYLESTOWN, Pa, – Bioclinica®, a world-leading provider of specialty clinical trial services, has appointed David Herron as the company's next Chief Executive Officer, effective January 2, 2018. This follows the planned retirement of current Chief Executive Officer, John Hubbard, PhD, who will remain as a non-Executive Director on the Bioclinica Board.

With more than 10 years' of experience at Bioclinica, David Herron has led the company's Medical Imaging business to great success. During his tenure, he integrated three of the industry's leading medical imaging companies (Bioclinica, Corelab Partners, and Synarc) into one comprehensive service provider. Focusing on both operational excellence and process efficiency, Herron has grown the business into the world’s largest independent supplier of medical imaging services for clinical trials.

Recently Herron assumed the additional responsibility of leading Bioclinica’s technology-focused eHealth segment, immediately creating new synergies that leverage Bioclinica's multi-faceted capabilities. With appointment to CEO, his oversight will extend to Bioclinica’s network of investigator sites and patient recruitment businesses for a unified clinical trial service offering unmatched in the industry.

Herron has more than 25 years' experience in healthcare technology, medical services and consulting, having worked at Ernst & Young, Caremark/CVS, HealthNet, and Webify Solutions/IBM.

David Herron

 

Dr. John Hubbard, current Chief Executive Officer of Bioclinica said, “It has been a privilege to serve as Chief Executive of Bioclinica for the past three years, however, now is the right time for me to take on a new role and welcome David to the Board.  This key transition has been core in our succession planning process. I've seen David successfully assume greater responsibility in the organization where he’s been integral in Bioclinica’s transformation over the last four years. I have every confidence in his ability to lead Bioclinica in the next phase of growth.”

 

David Herron

 

Herron commented, “I would like to thank John for his significant contribution as Chief Executive of Bioclinica for the last three years and I look forward to continue working with him in his new capacity as non-Executive Director. I am excited by the prospect of continuing to build and enhance Bioclinica's technology and service offering and working to help our clients improve clinical trial outcomes in the years ahead.”

About Bioclinica

Bioclinica is a global life science provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. The company's offerings include medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments and budget forecasting; pharmacovigilance, and trial management. The company's thousands of employees serve more than 500 pharmaceutical, biotechnology and device organizations – including all top 20 biopharmaceutical companies and leading CROs – through offices in North America, Europe, and Asia.

 

###

 

Media Contact
Nicole Klatsky
+1 (609) 865-5212
nicole.klatsky@bioclinica.com

 

 

Learn more about Bioclinica at www.Bioclinica.com and in the Bioclinica Blog. Follow the latest company news and happenings on LinkedIn and Twitter.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Bioclinica's #ClinicalDataManagement ecosystem of global experts, templates, coding tools and more fills the gap in… https://t.co/W5swfW70Ws
Bioclinica (3 days ago)
Not sure what questions to ask your clinical adjudication provider when transitioning a project to a new provider?… https://t.co/Tb2TXXuNa9
Bioclinica (4 days ago)
A clinical trial rescue or transition presents a unique set of challenges for study teams. Join us on July 21 for a… https://t.co/whD4O3w6QB
Bioclinica (1 week ago)
Save time and minimize risk with Bioclinica’s Clinical Trial Management System (CTMS) Starter Package. A fully feat… https://t.co/AgcXHWCg80
Bioclinica (2 weeks ago)
It takes a village to manage #clinicaltrial data. Watch our video to learn how to leverage our Clinical… https://t.co/F7yof0B6zH
Bioclinica (2 weeks ago)
The Clinical Trial Management System (CTMS) Starter Package from Bioclinica saves time and minimizes the risk often… https://t.co/EDhe0Qokla
Bioclinica (3 weeks ago)